CClinicalTrials.gg
TerminatedNCT01421446Updated Apr 1, 2015

Study to Validate a Computerized Neuropsychological Test Battery

An observational study in Healthy Elderly, sponsored by LifeBridge Health. Terminated at 1 site in United States. Open to participants aged 60 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-04-01.

Sponsored by LifeBridge Health · Observational

Why this study was terminated
Insufficient subject recruitment
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
1
Ages
60 Years to 80 Years
Sex
All
01

Study summary

This study is comparing a new computer-based method of administering neuropsychological tests to the standard method of verbal and paper/pencil tests administered in person by an examiner. The purpose of the research is to determine if the computerized and standard testing methods are equivalent.

Read the detailed description

Cognitive decline is one of the primary symptom triad of Normal Pressure Hydrocephalus (NPH). Neuropsychological measures have been demonstrated as being effective in the diagnosis of NPH, and in assessing the efficacy of treatment intervention. Hence, neuropsychological assessment is a critical component in the assessment for the presence of NPH. Specifically, measures of attention/concentration, fine motor skills, executive functioning abilities, speed of processing and memory have been found to be useful in the assessment of NPH and treatments thereof.

Neuropsychologists are typically found in large hospitals, academic centers and in urban locations. Neuropsychologists are under represented in rural or low population centers. At the present time, cognitive assessment is frequently limited to a Mini Mental Status Examination. Furthermore, neuropsychological testing can be very expensive for patients, given insurance constraints. Finally, there is no standardized test battery that is used in different centers treating this patient population. The creation of a standard battery that could be used in other NPH centers would promote research collaboration.

A computerized neuropsychological test battery was developed in Umea, Sweden with the specific goal of using tests that are considered to be sensitive to the cognitive profile observed in NPH. The battery was developed in JAVA and Adobe Flash making it platform independent (Runs on Mac, Windows and Linux). The test battery is administered on a touch screen display, where the tests are presented through animations with audio instructions. Before the real test trails are administered, subjects are given practice trials with auditory and visual feedback. For the American version of the test, the auditory stimuli have been translated and recorded in English.

02

Conditions studied

  • Healthy Elderly

Keywords

  • Neuropsychology
03

In context

Lead sponsor

LifeBridge Health is the lead sponsor of 31 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy elderly subjects without significant neurologic, psychiatric, cardiovascular, or other systemic disease that impairs neurologic function or cognitive function

Inclusion criteria

  • Age 60-80

Exclusion criteria

Exclusion Criteria:

  • Neurological disorder that results in motor or cognitive dysfunction
  • Perceptual or motor difficulties that would prevent subjects from taking the assessment
  • MMSE score \<20
  • MoCA score \<26
  • MAS score >9
  • Significant abnormal neurologic examination findings
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
1 participant (actual)
06

What researchers measure

Primary outcomes

  1. Computer Hydrocephalus Neuropsychological Assessment Versions 1 & 2

    Time frame: Within 2-5 weeks of enrollment

  2. Standard Hydrocephalus Neuropsychological Assessment: Versions 1 & 2

    Time frame: Within 2-5 weeks of enrollment

07

Study locations

1 site
  • Sandra and Malcolm Berman Brain & Spine Institute
    Baltimore, Maryland 21209, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 1, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01421446
Lead sponsor
LifeBridge Health
Responsible party
Michael Williams (Medical Director, Sandra and Malcolm Berman Brain & Spine Institute, LifeBridge Health) — Principal investigator
First posted
Aug 22, 2011
Start date
Sep 2011
Primary completion
Sep 2013
Completion
Dec 2013
Last update
Apr 1, 2015

Study contacts

Michael A Williams, MD
principal investigator · LifeBridge Health

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion